| Schedule of Earnings Per Share Available to Common stockholders |
The
following table sets forth the computation of the Company’s basic and diluted net loss per share available to common stockholders
during the three and nine months ended September 30, 2021 and 2020 (unaudited):
Schedule
of Earnings Per Share Available to Common stockholders
| |
|
2021 |
|
|
2020 |
|
|
2021 |
|
|
2020 |
|
| |
|
Three Months Ended
September 30,
|
|
|
Nine Months Ended
September 30,
|
|
| |
|
2021 |
|
|
2020 |
|
|
2021 |
|
|
2020 |
|
| Numerator |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net income (loss) from continuing operations |
|
$ |
785,565 |
|
|
$ |
(6,025,885 |
) |
|
$ |
(4,371,860 |
) |
|
$ |
(9,697,922 |
) |
| Deemed dividends |
|
|
(259,530,999 |
) |
|
|
(63,544,950 |
) |
|
|
(409,142,478 |
) |
|
|
(66,695,318 |
) |
| Net loss available to common stockholders, continuing operations |
|
|
(258,745,434 |
) |
|
|
(69,570,835 |
) |
|
|
(413,514,338 |
) |
|
|
(76,393,240 |
) |
| Net income (loss) from discontinued operations |
|
|
545,399 |
|
|
|
(166,180 |
) |
|
|
10,880,148 |
|
|
|
(164,293 |
) |
| Net loss available to common stockholders |
|
$ |
(258,200,035 |
) |
|
$ |
(69,737,015 |
) |
|
$ |
(402,634,190 |
) |
|
$ |
(76,557,533 |
) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Denominator |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Basic and diluted weighted average shares of common stock outstanding |
|
|
438,998,913 |
|
|
|
1,284 |
|
|
|
150,459,817 |
|
|
|
1,086 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Loss per share available to common stockholders- basic and diluted: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Continuing operations |
|
$ |
(0.59 |
) |
|
$ |
(54,182.89 |
) |
|
$ |
(2.75 |
) |
|
$ |
(70,343.68 |
) |
| Discontinued operations |
|
$ |
0.00 |
|
|
$ |
(129.42 |
) |
|
$ |
0.07 |
|
|
$ |
(151.28 |
) |
| Total basic and diluted |
|
$ |
(0.59 |
) |
|
$ |
(54,312.31 |
) |
|
$ |
(2.68 |
) |
|
$ |
(70,494.96 |
) |
|
| Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share |
Diluted
loss per share excludes all dilutive potential shares if their effect is anti-dilutive. As of September 30, 2021 and 2020, the following
potential common stock equivalents were excluded from the calculation of diluted loss per share as their effect was anti-dilutive:
Schedule
of Antidilutive Securities Excluded from Computation of Earnings Per Share
| |
|
2021 |
|
|
2020 |
|
| |
|
September 30, |
|
| |
|
2021 |
|
|
2020 |
|
| Warrants |
|
|
182,663,835,039 |
|
|
|
335,461 |
|
| Convertible preferred stock |
|
|
89,770,798,934 |
|
|
|
313,808 |
|
| Convertible debentures |
|
|
9,664,944,444 |
|
|
|
51,133 |
|
| Stock options |
|
|
26 |
|
|
|
26 |
|
| Dilutive
potential shares |
|
|
282,099,578,443 |
|
|
|
700,428 |
|
|